type 2 diabetes

The Match Game

August 17, 2017

Read the original article by Lori Lesko from Drug Discovery News. KANNAPOLIS, N.C.—Mixing and matching or repurposing drugs developed for one disease to treat another is nothing new, but Dr. Xiaohe Yang, senior researcher and associate professor at North Carolina Central University (NCCU), may have come up with an ideal match. Yang has discovered that well-known […]

Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans.

April 16, 2015

Does Type 2 Diabetes Genetic Testing and Counseling Reduce Modifiable Risk Factors? A Randomized Controlled Trial of Veterans. 2015 Apr 16, J Gen Intern Med., Voils CI1, Coffman CJ, Grubber JM, Edelman D, Sadeghpour A, Maciejewski ML, Bolton J, Cho A, Ginsburg GS, Yancy WS Jr. 1Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical […]

Patient Beliefs and Behaviors About Genomic Risk for Type 2 Diabetes: Implications for Prevention

April 06, 2015

Patient Beliefs and Behaviors About Genomic Risk for Type 2 Diabetes: Implications for Prevention, 2015 Apr 6, J Health Commun, Gallagher P1, King HA, Haga SB, Orlando LA, Joy SV, Trujillo GM, Scott WM, Bembe M, Creighton DL, Cho AH, Ginsburg GS, Vorderstrasse A. Altisource, Inc. , Winston-Salem , North Carolina , USA. Abstract Type 2 diabetes is […]

Scientific coalition studies plants’ role in fighting disease

July 28, 2014

By Hannah Miller View the article as published in the Charlotte Observer. View the article as published in the Raleigh News & Observer. In the worldwide search to learn more about plants’ role in fighting human disease, an unusual coalition has formed at North Carolina Research Campus in Kannapolis. It’s made up of academic and […]

Utility of large consanguineous family-based model for investigating the genetics of type 2 diabetes mellitus.

June 30, 2014

Utility of large consanguineous family-based model for investigating the genetics of type 2 diabetes mellitus. Jun 30,2014 Al-Sinani S1, Hassan MO2, Zadjali F2, Al-Yahyaee S2, Albarwani S2, Rizvi S2, Jaju D2, Comuzzie A3, Voruganti VS4, Bayoumi R2. 1College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman. Electronic address: Sawsan.alsinani@gmail.com. 2College of Medicine & Health Sciences, […]

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes

June 12, 2014

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes The Lancet, June 2014. RR Holman, H Sourij, RM CaliffDiabetes Trials Unit, University of Oxford, Oxford, UK; Division of Endocrinology and Metabolism, Medical University of Graz, Graz, Austria; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA 1Diabetes Trials Unit, University of Oxford, […]

What is Diabetes?

November 15, 2013

According to the American Diabetes Association: Diabetes is a problem with your body that causes blood glucose or sugar levels to rise higher than normal. Type 2 diabetes is the most common form of the disease. If you have type 2 diabetes your body does not use insulin properly. This is called insulin resistance.  At first, your pancreas makes extra insulin, but, […]

Cabarrus Health Alliance receives $1.8 million grant for Type 2 diabetes

May 30, 2012

by Emily Ford, Salisbury Post Link to original article KANNAPOLIS — The Cabarrus Health Alliance will receive $1.8 million from Duke University as part of a federal grant to help improve Type 2 diabetes care and reduce the cost of managing the disease. The award will create seven new jobs in Cabarrus County, including community […]

Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers

March 19, 2009

Bao, Y., Zhao, T., Wang, X., Qiu, Y., Su, M., Jia, W.*Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers, Journal of Proteome Research(IF = 5.675), 8(4), 1623-1630, 2009. Abstract The pathological development and the drug intervention of type 2 diabetes mellitus (T2DM) involve altered expression of downstream low molecular weight […]